LOCALLY ADVANCED GASTRIC CARCINOMA
Clinical trials for LOCALLY ADVANCED GASTRIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED GASTRIC CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED GASTRIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat cancers: drug targets DNA repair weakness
Disease control Recruiting nowThis phase 2 trial is testing the drug talazoparib in people with advanced solid tumors that have specific mutations in DNA repair genes. Talazoparib works by blocking a protein called PARP, which cancer cells use to fix their damaged DNA, leading to cancer cell death. The study …
Matched conditions: LOCALLY ADVANCED GASTRIC CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug combo aims to outsmart HER2-Positive cancers
Disease control Recruiting nowThis early-stage study tests a combination of two drugs—trastuzumab deruxtecan and azenosertib—in people with HER2-positive stomach, gastroesophageal junction, or other solid tumors that have spread or can't be removed by surgery. The goal is to find the safest dose and check for…
Matched conditions: LOCALLY ADVANCED GASTRIC CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Arterial chemo combo shows promise in stomach cancer trial
Disease control Recruiting nowThis phase 3 trial tests whether giving chemotherapy directly into the artery (instead of through a vein) along with immunotherapy can better shrink locally advanced stomach cancer before surgery. About 190 participants will receive either the standard chemo regimen or the arteri…
Matched conditions: LOCALLY ADVANCED GASTRIC CARCINOMA
Phase: PHASE3 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can a common drug help cancer patients regain appetite?
Symptom relief Recruiting nowThis study tests whether olanzapine, a drug already used for other conditions, can help cancer patients who are losing weight and appetite. About 66 adults with advanced lung, stomach, or bowel cancers will receive either olanzapine or a placebo. The goal is to see if olanzapine …
Matched conditions: LOCALLY ADVANCED GASTRIC CARCINOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC